← Back to headlines
Bank of America Raises McKesson Target on Biosimilar Push
Bank of America has raised its price target for McKesson (MCK) to $1,040, seeing upside potential from the company's biosimilar initiatives.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
